Sponsor of the Day:
Jerkmate
https://reports.investors.vodafone.com/view/268784920/
Q1 FY26 Q&A Transcript
q1 fy26transcript
https://reports.investors.vodafone.com/view/268784920/12/
Q1 FY26 Q&A Transcript - Page 12
11 Vodafone Group Plc Deutsche Numis Goldman Sachs New Street Research Bank of America Merrill Lynch BNP Paribas Exane Bernstein SocGen Kepler Cheuvreux
q1 fy26transcript12
https://www.techmonitor.ai/hardware/silicon/microchip-q1-fy2026-chip-demand-recovery
Microchip anticipates higher revenue and profit in Q1 FY26 amid chip demand recovery
May 9, 2025 - Microchip projected its financial performance for the upcoming Q1 FY26, expecting both revenue and profit to surpass analysts' estimates.
higher revenueq1 fy26chip demandmicrochipanticipates
https://www.investis-live.com/vodafone/685c1ff52166d0000f1cae35/vava
Viewing "Vodafone Group Q1 FY26 Trading Update Live Q&A"
viewing vodafone groupfy26 trading updatelive qq1
https://www.prnewswire.com/in/news-releases/exicom-q1-fy26-navigating-a-soft-quarter-with-clear-momentum-for-the-road-ahead-302528974.html
Exicom Q1 FY26: Navigating a Soft Quarter with Clear Momentum for the Road Ahead
Aug 13, 2025 - /PRNewswire/ -- Exicom Tele-Systems Limited (NSE: EXICOM), one of India's leading EV charging and critical power solutions manufacturers, today announced its...
q1 fy26road aheadnavigatingsoftquarter
https://www.hpcmagmea.com/2026/05/07/iff-reports-strong-q1-2026-results-with-usd-2-7b-in-sales/
IFF reports strong Q1 FY26 results with USD 2.7B in sales | Home & Personal Care Middle East &...
May 7, 2026 - The performance shows solid execution and steady operations within the company.
reports strong q1fy26 resultspersonal caremiddle eastiff
https://reports.investors.vodafone.com/view/137770051/
Vodafone Q1 FY26 Trading Update
Vodafone Q1 FY26 Trading Update
fy26 trading updatevodafoneq1
https://finance.yahoo.com/sectors/healthcare/articles/edwards-lifesciences-raises-fy26-guidance-142546657.html
Edwards Lifesciences raises FY26 guidance following strong Q1
Apr 24, 2026 - Edwards Lifesciences revealed that its Q1 2026 performance was better than expected, prompting it to uplift its previous FY26 outlook.
edwards lifesciencesguidance followingstrong q1raisesfy26